Zur Rose brings Sfr200m rights issue to fund German M&A
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
EquityFollow-ons and Rights issues

Zur Rose brings Sfr200m rights issue to fund German M&A

Matterhorn_fotolia_230x150

Zur Rose, the Swiss online pharmacy that went public last year, plans to raise Sfr200m via a rights issue to fund its takeover of the e-commerce operations of Medpex, a competitor in Germany.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article